Molecule Group (MOL) Share Price, News & Analysis

Company Overview

Key Stats

• Today's Range: 202 to 207
• 50-Day Range: N/A
• 52-Week Range: 202 to 220
• Volume: 48,903 shs
• Average Volume: 38,997 shs
• Market Capitalization: £55.10 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: GBX 308
• Consensus Rating: Buy

Molecule Group Stock Analysis - MarketRank™

Molecule Group scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

Molecule Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

Molecule Group has a consensus price target of GBX 308, representing about 52.5% upside from its current price of GBX 202.

Amount of Analyst Coverage

Molecule Group has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Molecule Group is -10.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for MOL.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Molecule Group does not currently pay a dividend.

Dividend Growth

Molecule Group does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Molecule Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net £49,184 in company stock, which represents 0.0893% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Molecule Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought £49,184 in company stock and sold GBX 0 in company stock.

Percentage Held by Insiders

5.58% of the stock of Molecule Group is held by insiders.

Percentage Held by Institutions

21.71% of the stock of Molecule Group is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: LON:MOL
• CIK: N/A
• Web: molecularenergiesplc.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Molecule Group: GBX 308
• High Price Target: GBX 308
• Low Price Target: GBX 308
• Potential Upside/Downside: +52.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: £10.03 million
• Price / Sales: 5.49
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 27,275,000
• Free Float: N/A
• Market Cap: £55.10 million
• Optionable: N/A
• Beta: N/A